Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
International Journal of STD & AIDS|April 20, 2000
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.
Virology Journal|June 13, 2023
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller womanL Di Girolamo, M Ferrara, G Trevisan, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2007
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virusD Aguilar Marucco, L Veronese, D Gonzalez de Requena, et al.
HIV Medicine|May 16, 2018
Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disordersM Trunfio, D Vai, C Montrucchio, et al.
Infection|December 3, 2011
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot studyS Bonora, A Calcagno, C Cometto, et al.
Journal of Neurovirology|January 19, 2022
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disordersA Barco, S Orlando, G Stroffolini, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2015
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)S Bonora, S Rusconi, A Calcagno, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical settingD González de Requena, S Bonora, S Garazzino, et al.
AIDS (London, England)|April 15, 1999
Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian randomized MAC treatment trial. Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, P Phillips, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpesS L Sacks, S D Shafran, F Diaz-Mitoma, et al.
Pageof 15